7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
      
                         
      cash flows from operating activities:
                         
      net income
    -212,830,000 -166,573,000 -140,718,000 -137,080,000 -103,124,000 -128,703,000 -95,020,000 -180,801,000 -92,664,000 -68,339,000 -60,462,000 -78,050,000 -57,917,000 -48,532,000 -38,986,000 -28,563,000 -26,615,000 -23,679,000 -21,220,000 -20,737,000 -21,018,000 
      adjustments to reconcile net income to net cash from operating activities:
                         
      depreciation and amortization
    3,064,000 2,879,000 2,956,000 2,864,000 1,788,000 1,352,000 999,000 888,000 806,000 750,000 712,000 702,000 684,000 609,000 582,000 459,000 510,000 484,000 347,000 332,000 334,000 
      stock-based compensation expense
    35,306,000 36,927,000 30,615,000 24,370,000 21,265,000 21,558,000 17,629,000 13,348,000 13,220,000 12,544,000 9,648,000 7,009,000 6,648,000 5,894,000 4,099,000 3,158,000 2,937,000 2,769,000 1,865,000 1,935,000 1,838,000 
      amortization of operating lease right-of-use assets
    2,133,000 2,110,000 1,918,000 1,921,000 2,703,000 2,126,000 2,092,000 2,060,000              
      net accretion of discounts on investments
    -2,264,000 -4,493,000 -4,913,000 -11,676,000 -6,103,000 -9,934,000 -10,991,000               
      unrealized foreign exchange gain
    -789,000                     
      changes in operating assets and liabilities:
                         
      prepaid expenses and other current assets
    915,000 -6,667,000 -1,499,000 -3,297,000 -566,000 2,994,000 -4,958,000 15,439,000 7,124,000 9,000 -4,702,000 -2,419,000 1,830,000 -1,769,000 2,791,000 8,937,000 -9,936,000 -5,813,000 -557,000 982,000 -776,000 
      operating lease right-of-use assets
    -17,575,000 -45,324,000                  
      other assets
    -11,316,000 -10,477,000 -6,554,000 -4,459,000 -6,925,000 -6,546,000 -8,581,000 -34,370,000 286,000 462,000 615,000 69,000 802,000 241,000 -1,577,000 -509,000 -3,074,000 485,000 -441,000 -108,000 -11,000 
      operating lease liabilities
    -1,401,000 -1,364,000 15,999,000 43,151,000 2,378,000 -1,839,000 -1,804,000 15,416,000 -1,400,000 -1,376,000 -1,356,000 -1,840,000 -1,423,000 -1,205,000 5,619,000 -12,781,000 232,000 -202,000 -105,000   
      accounts payable
    17,877,000 9,525,000 -29,163,000 31,309,000 8,311,000 -10,708,000 5,672,000 6,479,000 694,000 2,263,000 1,789,000 3,471,000 -1,354,000 2,712,000 -1,933,000 -18,071,000 1,498,000 1,918,000 2,185,000 18,772,000 8,129,000 
      accrued compensation
    5,948,000 4,546,000 -14,418,000 8,343,000 5,767,000 3,375,000 -7,968,000 4,131,000 2,510,000 2,536,000 699,000 -2,271,000 1,391,000 790,000 -2,185,000 1,379,000 665,000 403,000 723,000 -1,206,000 758,000 
      accrued contract manufacturing expenses
    19,987,000 35,129,000 8,088,000                   
      accrued expenses
    65,000 2,999,000 -4,393,000 -9,319,000 8,635,000 -30,615,000 -4,354,000 36,806,000 -2,737,000 -812,000 3,038,000 1,694,000 3,919,000 2,295,000 -737,000 -3,817,000 4,927,000 2,379,000 1,142,000 791,000 -576,000 
      net cash from operating activities
    -143,305,000 -121,166,000 -166,274,000 -111,401,000 -60,708,000 -121,394,000 -159,124,000 -128,810,000 -57,548,000 -62,742,000 -47,690,000 -65,221,000 -38,548,000 -39,126,000 -27,702,000 -51,093,000 -28,415,000 -28,680,000 -13,205,000 -10,768,000 -13,055,000 
      capex
    -1,727,000 -2,229,000 -1,535,000 3,629,000 -4,697,000 -16,221,000 8,041,000 2,823,000 -11,068,000 6,245,000 -5,552,000 -1,178,000 -1,231,000 -1,073,000 -2,256,000 -887,000 -1,923,000 -3,270,000 291,000 -377,000 -29,000 
      free cash flows
    -145,032,000 -123,395,000 -167,809,000 -107,772,000 -65,405,000 -137,615,000 -151,083,000 -125,987,000 -68,616,000 -56,497,000 -53,242,000 -66,399,000 -39,779,000 -40,199,000 -29,958,000 -51,980,000 -30,338,000 -31,950,000 -12,914,000 -11,145,000 -13,084,000 
      cash flows from investing activities:
                         
      purchases of property and equipment
    -3,824,000 -1,811,000 -5,424,000 -4,021,000 -4,947,000 -7,781,000 -5,678,000 -5,254,000 -7,339,000 2,140,000 -5,609,000 -1,147,000 -843,000 -938,000 -2,920,000 -1,382,000 -1,719,000 -2,208,000 -1,246,000 -722,000 -29,000 
      purchases of manufacturing facility build-out and equipment construction-in-progress
    -8,222,000 -7,944,000 -21,327,000                   
      purchases of investments
    -255,315,000 -349,050,000 -314,485,000 -815,215,000 -1,233,140,000 -350,649,000 -687,697,000 -203,610,000 -209,673,000 -432,834,000 -483,779,000 -71,285,000 -17,591,000 -6,897,000 -6,972,000 -41,062,000 -66,748,000 -56,386,000 -172,145,000   
      maturities of investments
    350,200,000 394,476,000 438,488,000 263,547,000 327,700,000 299,670,000 242,318,000 242,957,000 232,920,000 95,839,000 40,160,000 32,500,000 46,140,000 30,500,000 59,551,000 42,500,000 37,000,000     
      sales of investments
    38,331,000 42,071,000 26,065,000 24,527,000 26,501,000           12,998,000     
      net cash from investing activities
       -557,168,000 -917,019,000 -80,406,000 -451,073,000 -13,926,000 22,280,000 -333,564,000 -448,101,000 -35,952,000 34,706,000 26,165,000 49,666,000 82,000 -18,469,000 -20,530,000 -173,391,000 -722,000 21,000 
      cash flows from financing activities:
                         
      proceeds from issuance of shares through employee equity incentive plans
    306,000                     
      proceeds from issuance of common stock from at-the-market offerings, net of issuance costs
                         
      proceeds from issuance of common stock from follow-on offerings, net of issuance costs
        1,423,176,000                 
      taxes paid related to the net share settlement of equity awards
    -3,977,000 -717,000 -5,290,000                   
      net cash from financing activities
    -3,671,000 2,518,000 759,000 4,907,000 1,515,037,000 110,368,000 818,196,000 2,735,000 48,550,000 546,966,000 41,562,000 656,633,000 44,017,000 49,878,000 111,019,000 8,754,000 7,599,000 956,000 487,000 555,000 36,000 
      effect of exchange rate changes on cash and cash equivalents
    291,000 800,000 1,172,000 1,350,000 -5,576,000 -1,410,000 6,062,000 -7,682,000 1,051,000 -78,000 23,000 796,000 53,000 -485,000 -227,000 -802,000 333,000 311,000 -281,000   
      net increase in cash, cash equivalents and restricted cash
    -25,515,000 -40,106,000 -41,026,000 -662,312,000 531,734,000 -92,842,000 214,061,000 -147,683,000 14,333,000 150,582,000 -454,206,000 556,256,000 40,228,000 36,432,000 132,756,000 -43,059,000 -38,952,000 -47,943,000 -186,390,000   
      cash, cash equivalents and restricted cash, beginning of period
    389,195,000 398,554,000 835,528,000 69,856,000 386,200,000   
      cash, cash equivalents and restricted cash, end of period
    -25,515,000 -40,106,000 348,169,000 -662,312,000 531,734,000 -92,842,000 612,615,000 -147,683,000 14,333,000 150,582,000 381,322,000 556,256,000 40,228,000 36,432,000 202,612,000 -43,059,000 -38,952,000 -47,943,000 199,810,000   
      reconciliation of cash, cash equivalents and restricted cash:
                         
      cash and cash equivalents
    -25,664,000 -40,106,000 346,850,000                   
      restricted cash
    149,000 1,319,000                   
      cash, cash equivalents and restricted cash
    -25,515,000 -40,106,000 348,169,000                   
      supplemental disclosure of non-cash investing and financing activities:
                         
      purchases of property and equipment recorded in accounts payable and accrued expenses
    2,097,000 -418,000 3,889,000 7,650,000 250,000 -8,440,000 13,719,000 8,077,000 -3,729,000 4,105,000 57,000 -31,000 -388,000 -135,000 664,000 495,000 -204,000 -1,062,000 1,537,000 345,000  
      net cash provided (used) in investing activities
     77,742,000 123,317,000                   
      proceeds from issuance of common stock from at-the-market offering, not yet received
                         
      unrealized foreign exchange loss
      -6,617,000                   
      proceeds from exercise of common stock options
      6,049,000  11,737,000 2,744,000 5,024,000 2,067,000 2,155,000 884,000 502,000 2,532,000 1,757,000 324,000 282,000 1,568,000 491,000 466,000 487,000 181,000 108,000 
      supplemental disclosure of non-cash investing activities:
                         
      non-cash payments for acquired manufacturing rights
                         
      proceeds from issuance of common stock and pre-funded warrants from follow-on offerings, net of issuance costs
                         
      proceeds from issuance of common stock under at-the-market offering, net of issuance costs
                         
      supplemental disclosures of non-cash investing and financing activities:
                         
      issuance of common stock for acquired manufacturing rights
                         
      unrealized foreign exchange gains
                         
      accrued manufacturing expenses
        16,240,000 35,546,000 -51,840,000 10,887,000 27,511,000 -586,000 6,689,000 -2,004,000 5,440,000 -2,026,000 2,416,000 -2,593,000 -366,000 -8,138,000 2,525,000 -11,528,000 -1,744,000 
      purchases related to manufacturing facility and equipment construction-in-progress
        -33,133,000                 
      proceeds from issuance of common stock related to at-the-market offerings, net of issuance costs
        89,460,000                 
      release of restricted stock units
        -9,336,000 -565,000 -3,306,000 -330,000 -2,605,000 -214,000 -727,000          
      proceeds from issuance of common stock under employee stock purchase plan
          1,021,000             
      manufacturing facility and equipment construction-in-progress
          -6,394,000               
      sale of investments
          6,378,000  6,372,000 1,291,000 1,127,000  7,000,000         
      proceeds from issuance of common stock related to at-the-market offering, net of issuance costs
            49,000,000 41,787,000    3,115,000       
      proceeds from issuance of common stock from follow-on offering, net of issuance costs
          816,478,000             
      loss on disposal of assets
                       2,000 16,000 
      asset impairment charges
               156,000 57,000     
      net amortization (accretion) of premium (discounts) on investments
                         
      proceeds from sales of property and equipment
                         
      proceeds from issuance of common stock under atm sales program, net of issuance costs
                         
      supplemental disclosure of cash flow information:
                         
      cash paid for interest
                   
      stock issued for payment of accounts payable
                   1,000     
      net amortization (accretion) of premiums (discounts) on investments
                         
      loss on disposal of fixed assets
                44,000       
      proceeds from sale of property and equipment
                7,000      
      amortization of operating right-of-use assets
             1,651,000 1,630,000  1,670,000 1,564,000 1,787,000  346,000 384,000 180,000   
      net amortization of premiums on investments
             -11,844,000 -5,990,000 -1,175,000 -238,000 145,000 321,000 496,000 429,000 330,000 151,000   
      deferred offering costs included in accounts payable and accrued expenses
                 -22,000 23,000       
      change in fair value of redeemable convertible preferred stock warrant
                       
      deferred rent and other long-term liabilities
                       -3,000 -5,000 
      payments of capital lease obligations
                       
      proceeds from initial public offering, net of issuance costs
                         
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
                       
      proceeds from issuance of common stock related to early exercised stock options
                       
      proceeds from issuance of common stock under the employee stock purchase plan
               483,000   398,000     
      conversion of convertible preferred stock into common stock
                       
      proceeds from issuance of common stock related to at-the-market offering, net of commissions and offering expenses
                43,121,000         
      proceeds from issuance of common stock through atm facility not yet received
                         
      proceeds from follow-on public offering, net of underwriters' commissions and discounts
                  107,622,000       
      change in fair value of redeemable convertible preferred stock tranche liabilities
                         
      proceeds from initial public offering, net of underwriters' commissions and discounts
                       
      payment of issuance costs for initial public offering
                       -72,000 
      payments of deferred offering costs
                         
      issuance costs for initial public offering included in accounts payable and accrued expenses
                        -1,492,000 
      deferred offering costs included in accrued expenses
                         
      expense on issuance of redeemable convertible preferred stock warrant
                         
      accrued legal settlement
                         
      net increase in cash and cash equivalents
                       -10,848,000 -12,998,000 
      cash and cash equivalents, beginning of period
                       
      cash and cash equivalents, end of period
                       -10,848,000 -12,998,000 
      purchases of property and equipment recorded in accounts payable
                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.